Blog

Russ Cohen

Most Popular

Unleashing the Potential: ON Semiconductor’s Rise Above Nvidia Unleashing the Potential: ON Semiconductor’s Rise Above Nvidia

The market warmed to ON Semiconductor’s (NASDAQ: ON) second-quarter earnings report, and the stock has now significantly outperformed Nvidia over the last month, with a 14.2% increase compared to a 5.4% decline for the stock market darling (as of this writing). The question is why and whether it can continue. A Promising Cyclical Stock ON ...

Russ Cohen

Most Popular

Uncovering Opportunities: Analyzing Warren Buffett’s Fear Indicator Uncovering Opportunities: Analyzing Warren Buffett’s Fear Indicator

Warren Buffett’s Investment Strategy Warren Buffett, the renowned investor, doesn’t rely solely on luck when it comes to outperforming the market. With a staggering $168 billion in cash reserves, Berkshire Hathaway is strategically positioned to capitalize on market uncertainties. By leveraging high treasury yields to earn risk-free returns and embodying the essence of patience, Buffett ...

Russ Cohen

Most Popular

Unveiling Zentalis Pharmaceuticals, Inc. Investigation Unfolds for ZNTL Shareholders

Zentalis Pharmaceuticals, Inc., a promising entity under the NASDAQ ticker ZNTL, has stirred a hornet’s nest amongst investors. The esteemed Schall Law Firm, renowned for upholding shareholder rights, has taken the reins by initiating an investigation into potential securities law infringements. The crux of the matter lies in allegations of misleading disclosures and withheld critical ...

Russ Cohen

Most Popular

The Resilient 5-Stock Portfolio: Weathering Storms with High Yields The Resilient 5-Stock Portfolio: Weathering Storms with High Yields

Concerned about turbulent market conditions? Fearful of a financial tempest brewing both at home and overseas that could send stocks into a tailspin? If so, this quintet of stocks may be your financial life vest. Sporting a robust yield of up to 7.3%, these stocks are steadfastly constructed to brave economic Armageddon. They are the ...

Russ Cohen

Most Popular

Exploring the Validity of Wall Street’s Support for Netflix (NFLX) Deciphering Wall Street’s Enthusiasm for Netflix (NFLX)

Understanding Brokerage Recommendations Investors often look to Wall Street analysts for guidance on stock purchases. The opinions of brokerage analysts can sway market sentiment and impact stock prices. Netflix (NFLX) is currently enjoying an average brokerage recommendation (ABR) of 1.91, indicating a favorable outlook based on ratings by 39 brokerage firms. Analyzing Brokerage Recommendation Trends ...

Russ Cohen

Most Popular

Harley-Davidson’s Thriving Ride: A 13% Surge Post Q2 Earnings Triumph Harley-Davidson’s Thriving Ride: A 13% Surge Post Q2 Earnings Triumph

Harley-Davidson, Inc. (HOG) has kickstarted a roaring 13.3% ascent since the company flexed its financial muscle on Jul 25. Propelled by stellar earnings that overachieved expectations, the stock has catapulted skyward, leaving investors beaming with joy. The company’s top and bottom lines notched up remarkable year-over-year growth. To add fuel to the rally, Harley-Davidson also ...

Russ Cohen

Most Popular

Investing in the Future: A Deep Dive into Generative AI Stocks Investing in the Future: A Deep Dive into Generative AI Stocks

OpenAI’s groundbreaking ChatGPT has set the tech industry abuzz since its debut in the latter part of 2022. In the wake of its disruptive presence, numerous companies have honed in on the possibilities within generative AI, striving to forge technologies that can rival the prowess of ChatGPT. This article delves into the stocks of such ...

Russ Cohen

Most Popular

Unveiling the Performance of QQQ ETF

Recent Upswing Recent data indicates a positive trajectory for the Invesco QQQ ETF, exhibiting a 1.53% surge over the past five days. Impressively, its year-to-date increase stands at approximately 12.05%. Analyst Consensus A unique ETF analyst consensus from TipRanks reveals that QQQ is currently categorized as a Moderate Buy. Market experts have set an average ...

Russ Cohen

Most Popular

OVID Investors Have Opportunity to Join Ovid Therapeutics Inc. Fraud Investigation with the Schall Law Firm

Ovid Therapeutics Inc.: Uncovering Shadows in the Sky Unveiling Dubious Layers Recent developments at Ovid Therapeutics Inc. have sent ripples through the investor community, triggering an investigation by The Schall Law Firm. The focus is on whether Ovid made inaccurate disclosures that misled shareholders. A Rocky Road Unfolds The saga began when Takeda Pharmaceutical Company ...